Century Therapeutics Inc.

NASDAQ: IPSC · Real-Time Price · USD
0.56
0.01 (1.82%)
At close: Aug 15, 2025, 3:59 PM
0.58
3.17%
After-hours: Aug 15, 2025, 05:56 PM EDT

Century Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-21.94M -126.57M -129.89M -131.39M -133.47M -136.67M -128.96M -126.99M -124.68M -130.93M -127.44M -122.7M -114.99M -95.82M -83.16M -70.22M -62.25M
Depreciation & Amortization
13.3M 13.3M 13.54M 13.59M 13.36M 13.04M 12.33M 11.75M 10.19M 8.44M 6.65M 4.92M 4.19M 3.75M 3.21M 2.57M 1.92M
Stock-Based Compensation
11.91M 12.69M 13.59M 14.25M 14.03M 14.62M 13.79M 12.6M 12.09M 10.67M 9.57M 8.01M 6.95M 4.66M 3.4M 2.32M 750K
Other Working Capital
1.93M -7.81M -9.19M 1.02M 3.03M 11.74M 15.99M 7.51M 5.74M 128.73M 123.04M 123.39M 121.03M -949K 2.07M 3.58M 2.11M
Other Non-Cash Items
11.6M 20.99M 39.47M 39.98M 30.69M 20.61M -1.29M -317K 984K 1.93M 1.65M 1.39M 1.17M 1.21M 1.09M 928K 690K
Deferred Income Tax
870K 870K -13.55M -13.55M -9.33M -9.33M 4.22M 4.22M n/a n/a n/a n/a n/a n/a n/a n/a 4.72M
Change in Working Capital
-232K -9.28M -14.02M 936K 4.31M 9.38M 14.88M 3.11M -495K 123.94M 122.18M 121.25M 122.61M -2.8M -2.41M 1.28M -2.4M
Operating Cash Flow
-114.51M -110.14M -112.14M -97.46M -89.38M -88.35M -85.03M -95.61M -101.92M 14.05M 12.61M 12.86M 19.93M -89M -77.87M -63.11M -56.56M
Capital Expenditures
539K n/a -980K -5.05M -9.28M -13.74M -19.02M -25.57M -31.53M -30.6M -41.06M -46.98M -47.15M -44.97M -30.15M -18.92M -9.01M
Cash Acquisitions
-9.61M -9.61M 82.54M 75.06M 73.19M n/a -330.37M -355.36M -366.86M -348.9M -141.01M -108.54M -85.56M -30.34M n/a n/a -4.72M
Purchase of Investments
-84.46M -119.55M -111.84M -156.14M -201.29M -209.03M -249.68M -258.56M -193.77M -254M -245.55M -325.25M -308.24M -330.03M -325.07M -187.51M -173.23M
Sales Maturities Of Investments
114.74M 176.79M 157.88M 171.29M 251.91M 283.9M 306.96M 340.84M 287.54M 271.48M 257.15M 173.05M 132.06M 76.67M 56.71M 55.45M 49.35M
Other Investing Acitivies
18.67M -12.06M 7.69M 15.15M 50.62M 111.73M 330.37M 355.36M 366.86M 348.9M 141.01M -22.78M -46.77M -219.15M -268.36M -132.06M -135.77M
Investing Cash Flow
63.87M 47.48M 35.48M 497K 41.34M 61.13M 38.26M 56.7M 62.25M -13.13M -29.46M -199.18M -223.34M -298.34M -298.52M -150.99M -137.61M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-17.83M -17.83M n/a n/a -10.24M -10.24M -10.24M -10.24M n/a n/a 23K 24K 2.72M 36.53M 74.61M 84.21M 81.5M
Financial Cash Flow
56.49M 74.56M 74.81M 74.84M 8.02M -9.72M -9.27M -9.44M 728K 27.16M 27.17M 26.57M 251.17M 417.77M 455.77M 465.83M 241.18M
Net Cash Flow
7.83M 13.89M 125K -22.98M -40.02M -36.94M -56.04M -48.35M -38.95M 28.08M 10.32M -159.75M 47.76M 30.43M 79.38M 251.74M 47M
Free Cash Flow
-114.13M -110.29M -113.12M -102.51M -98.66M -102.08M -104.05M -121.19M -133.45M -16.55M -28.45M -34.12M -27.22M -133.97M -108.02M -82.04M -65.57M